The Effect of Augmented Reality Based Telerehabilitation Application on Neuromuscular and Sensorimotor Parameters in Multiple Sclerosis Patients

NCT ID: NCT05639517

Last Updated: 2023-02-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-30

Study Completion Date

2024-12-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Core stability, which is affected from the early period in with patients Multiple Sclerosis (PwMS), is due to deterioration in the somatosensory, motor and musculoskeletal systems. Based on the knowledge that core stability is effective on many functions, it is seen that trunk stabilization exercises are included in the physiotherapy and rehabilitation programs of patients. However, the effectiveness of augmented reality-based telerehabilitation application, which includes trunk stabilization training in PwMS, has not been adequately investigated in the literature. The aim of the study is to investigate the effectiveness of augmented reality-based telerehabilitation application, which includes trunk stabilization training, on neuromuscular and sensorimotor parameters in PwMS.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Patients in this group will receive spinal stabilization training through augmented reality based telerehabilitation application.

Group Type EXPERIMENTAL

Augmented Reality Based Telerehabilitation Application

Intervention Type OTHER

Spinal stabilization training with augmented reality-based telerehabilitation will be applied twice a week for 8 weeks.

Group 2

Patients in this group will receive spinal stabilization training face-to-face.

Group Type ACTIVE_COMPARATOR

Training face-to-face

Intervention Type OTHER

Spinal stabilization training will be applied face-to-face twice a week for 8 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Augmented Reality Based Telerehabilitation Application

Spinal stabilization training with augmented reality-based telerehabilitation will be applied twice a week for 8 weeks.

Intervention Type OTHER

Training face-to-face

Spinal stabilization training will be applied face-to-face twice a week for 8 weeks.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed with relapsing remitting MS by a neurologist,
* Having a disability level between 1 and 5 according to the Expanded Disability Status Scale (EDSS),
* Those who get over 24 points in the Standardized Mini Mental State Test (SMMT),
* Those who have not had an MS attack in the last three months,
* Volunteer individuals

Exclusion Criteria

* Receiving corticosteroid therapy in the last 4 weeks,
* Having additional neurological disease that may cause balance disorder
* Individuals who have had surgery related to the spine, hip, knee or ankle
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ankara Yildirim Beyazıt University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-985

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.